Beam Therapeutics Inc. (BEAM) Return on equity 2020–2025
Beam Therapeutics Inc. (BEAM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-6.5%FY2025 · since FY2020: -79.2% → -6.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -6.5% | +44.9 pp |
| FY2024 | -51.4% | -37.9 pp |
| FY2023 | -13.5% | +25.9 pp |
| FY2022 | -39.4% | +5.4 pp |
| FY2021 | -44.8% | +34.4 pp |
| FY2020 | -79.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BEAM financial trends
BEAM RevenueBEAM Net incomeBEAM Net marginBEAM Gross profitBEAM Gross marginBEAM Operating incomeBEAM Operating marginBEAM Operating cash flowBEAM Free cash flowBEAM Capital expendituresBEAM Stock buybacksBEAM Dividends paidBEAM Total assetsBEAM Total liabilitiesBEAM Shareholders’ equityBEAM overview →